← All Sponsors
SPONSOR

Karyopharm Therapeutics Inc

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Diffuse Large B-cell Lymphoma
NCT02227251 Phase 2
Recruiting

Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma
United States, Australia, Austria View Trial →